We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Latest Articles

The Importance of Understanding Target–Protein Interactions in Drug Discovery
Article

You’re unwell, you see a doctor, they prescribe you a medicine… and you take it. But how exactly is that drug having an effect? What is its mechanism of action? Drugs exhibit their effects through specific protein–target interactions. Andrew Lynn, Chief Executive Officer at Fluidic Analytics discusses why understanding protein–target interactions is so important.

READ MORE

Incidence vs Prevalence
Article

In epidemiology, prevalence and incidence are among the most fundamental measures when it comes to monitoring disease. But do you know what they mean or how and why they are important? This article takes a look at disease prevalence and incidence, what this information tells us and how it can be used.

READ MORE

Complementary Bonds: Strategic Collaboration Between ELRIG and BPS Announced at Pharmacology 2019
Article

A new collaboration was announced Monday between the British Pharmacological Society (BPS) and scientific not-for-profit The European Laboratory Research & Innovation Group (ELRIG) UK at the annual Pharmacology 2019 meeting in Edinburgh, Scotland.

READ MORE

The Pursuit of Spotting and Steering Cell Death
Article

Here, we examine one common branch of cell death, apoptosis, and explain why studying aberrations in apoptotic signaling is important for understanding and addressing a range of human pathologies. We also highlight techniques that enable studies of apoptosis.

READ MORE

Should Infectious Diseases Be Made Notifiable? The Good, the Bad and the Ugly
Article

At first glance this question might seem like a no-brainer. Surely if you make an infectious disease notifiable then you are better able to contain infection and prevent it spreading, right? Unfortunately, whilst the principle seems simple, the reality is far less so. Here we take a look at the different facets and implications of making an infectious disease notifiable.

READ MORE

The Power of Collaboration: Tackling Pharmaceutical Challenges
Article

In this article, we explore how pharmaceutical companies have started to embrace a more collaborative way of working as part of a movement to help overcome some of the challenges the industry is facing.

READ MORE

Biosecurity – From the Horse’s Mouth
Article

"Biosecurity” encompasses a wide range of important topics, from bioterrorism to invasive alien species of both plants and animals. But for the purposes of this article, we are going to focus on the prevention of outbreaks of disease and how to minimize the spread when they do inevitably happen.

READ MORE

Scientists Left Perplexed at Latest Alzheimer’s Drug Data
Article

In this article, we revisit the many twists and turns of the aducanumab clinical trials and explore the scientific community's response to the latest analysis of the data.

READ MORE

What is Pharmacovigilance?
Article

Pharmaceutical drugs are a valuable part of patient care throughout the world. For doctors to adequately care for their patients, drug safety must be monitored and reported from initial testing to everyday use. In this article, we explore the world of pharmacovigilance.

READ MORE

Future Cancer Immunotherapy Treatments Could Be Administered by a Pill
Article

Immunotherapies delivered in pill form aren’t yet the default cancer treatment. Techniques like protein painting are bringing that day closer.

READ MORE